Previous Article | Next Article ![]()
Infection and Immunity, January 2009, p. 367-373, Vol. 77, No. 1
0019-9567/09/$08.00+0 doi:10.1128/IAI.01057-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Department of Microbiology,1 College of Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois 618012
Received 25 August 2008/ Returned for modification 29 September 2008/ Accepted 18 October 2008
Interleukin-10 (IL-10)-deficient mice are resistant to several pathogens, including Yersinia pestis. Surprisingly, we observed that heterozygous IL-10+/– mice also survive high-dose intravenous infection with Y. pestis KIM5 (Pgm–). Analysis of commercial IL-10–/– mice revealed that at least 30 cM of genomic DNA from the original 129 strain remains, including a functional Slc11a1 (Nramp1) gene. Interestingly, two substrains of 129 mice were resistant to high-dose Y. pestis KIM5. Resistance does not appear to be recessive, as F1 mice (C57BL/6J x 129) also survived a high-dose challenge. A QTL-based genetic scan of chromosome 1 with 35 infected F1 backcrossed mice revealed that resistance to KIM5 maps to a region near IL-10. Two novel IL-10+/+ mouse strains which each possess most of the original 30-cM stretch of 129 DNA maintained resistance to high-dose infection with Y. pestis KIM5 even in a heterozygous state. Conversely, a novel IL-10–/– mouse strain in which most of the 129 DNA has been crossed out exhibited intermediate resistance to KIM5, while the corresponding IL-10+/– strain was completely susceptible. Taken together, these results demonstrate that 129-derived genomic DNA near IL-10 confers resistance to Yersinia pestis KIM5 and contributes to the observed resistance of IL-10–/– mice.
Published ahead of print on 27 October 2008.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»